Bio-Rad Laboratories BIO Cash Flow Statement (2009-2026)

NYSE BIO
$366.15 -4.35 (-1.17%)
At close: Nov 13, 2026 · 4:00 PM EST
Reported Financials

Bio-Rad Laboratories Quarterly Cash Flow Statement

Periods 71 quarters
Latest Sep 2026

Bio-Rad Laboratories reported cash from operations of $96.40M and free cash flow of $65.20M for the quarter ended Sep 2026, down 20.3% year over year. This cash flow statement covers 71 quarters of results from Mar 2009 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-1,565.26M-3,367.30M-925.10M-162.80M827.81M69.00M-1,162.30M106.30M136.90M383.90M-2,165.50M653.20M-715.80M64.00M317.80M-341.90M720.00M-527.10M371.40M458.60M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
Share-based CompensationStock Comp.
15.00M13.50M13.60M15.70M18.10M15.90M16.20M15.60M16.40M14.90M15.90M15.50M
Deferred Taxes
Gains from Sales and DivestituresGains Divest
Gains from Investment SecuritiesGains Investment
Asset Writedowns and ImpairmentWritedown
Other non-cash itemsOther Non-Cash
-819.10M35.90M-18.10M
Non-cash ItemsNon-Cash Items
Change in Working Capital
Change in ReceivablesChange Receivables
Change in InventoryChange Inventory
Change in Accrued ExpensesChange Accrued Exp.
Change in TaxesChange Taxes
Change in Other Operating AssetsOther Assets Change
Change in Other Operating LiabilitiesOther Liabilities Change
Other Working Capital ChangesOther WC Changes
Other Operating Activities (as filed)
22.76M30.76M29.64M34.76M-9.46M9.35M55.00M31.59M12.35M18.00M44.30M0.30M43.60M8.00M6.60M5.20M23.10M43.20M23.10M14.90M
Cash from OperationsCash from Ops.
170.90M50.50M53.30M11.00M79.60M98.12M98.08M97.70M81.00M69.80M97.60M163.60M124.20M129.90M116.50M120.90M164.90M108.10M98.70M96.40M
Investing Activities
Capital ExpendituresCapex
56.18M33.08M17.33M27.58M34.81M35.73M34.64M44.07M42.27M40.20M42.30M40.20M42.90M34.40M45.70M31.70M45.80M30.00M32.00M31.20M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.11M0.01M0.09M0.04M0.07M0.10M0.03M0.07M0.10M0.10M-0.10M
Change in Property, Plant and EquipmentChange in PP&E
-56.18M-33.08M-17.23M-27.57M-34.73M-35.73M-34.60M-44.01M-42.17M-40.17M-42.23M-40.20M-42.90M-34.40M-45.60M-31.70M-45.80M-29.90M-32.10M-31.20M
Change in IntangiblesChange Intangibless
49.80M
Acquisitions
125.52M-0.05M1.80M
Divestments
0.04M2.50M
Net of Acquisitions & DivestmentsNet Acquisitions
-125.52M0.09M2.50M-1.80M
Purchase of InvestmentsInvestments Purchased
391.57M960.94M517.49M328.72M253.05M203.59M137.93M196.02M151.46M406.50M248.00M399.20M222.90M153.40M153.20M223.90M138.80M226.10M184.20M267.40M
Sale and Maturity of InvestmentsInvestments Sold
459.28M77.88M388.88M368.61M230.63M168.84M200.52M230.52M263.32M403.60M259.30M407.10M235.30M190.70M300.10M214.40M150.40M162.80M148.50M152.70M
Change in Acquisitions & DivestmentsChange Acquisitions
Other Investing Activities (as filed)Other investing (as filed)
Cash from Investing ActivitiesCash from Investing
-567.43M-916.14M-144.48M-88.42M-58.56M-70.47M27.98M-9.50M72.19M-43.10M-30.90M-55.70M-30.50M2.90M-115.40M-43.00M-34.20M-93.20M-66.70M-145.90M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
1,186.22M-0.02M
Long-Term Debt RepaymentsLT Debt Repayment
1.38M0.10M0.15M0.11M0.13M0.12M0.12M0.12M0.15M0.20M0.10M0.10M0.10M0.20M0.20M0.10M0.20M0.10M
Net Long-Term Debt Issued (Repaid)Net LT Debt
-1.38M1,186.12M-0.15M-0.11M-0.15M-0.12M-0.12M-0.12M-0.15M-0.20M-0.10M-0.10M-0.10M-0.20M-0.20M-0.10M-0.20M-0.10M
Net Short-Term Debt Issued (Repaid)Net ST Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
-1.38M1,186.12M-0.15M-0.11M-0.15M-0.12M-0.12M-0.12M-0.15M-0.20M-0.10M-0.10M-0.10M-0.20M-0.20M-0.10M-0.20M-0.10M
Change in Capital Stock
Common Stock IssuedStock Issued
6.17M4.18M4.27M7.55M4.38M4.42M5.10M5.11M4.33M5.50M4.70M5.10M3.90M4.30M4.20M3.40M3.90M3.40M4.20M3.60M
Shares Repurchased
125.00M90.70M207.41M21.32M199.97M4.70M101.00M97.90M101.90M140.20M53.40M47.80M31.50M
Net Shares Issued and RepurchasedNet Shares Issued
6.17M4.18M-120.73M7.55M-86.32M4.42M-202.31M-16.21M-195.64M0.80M-96.30M-92.80M3.90M-97.60M-136.00M-50.00M3.90M-44.40M-27.30M3.60M
Net Equity Issued and RepurchasedNet Equity Issued
6.17M4.18M-120.73M7.55M-86.32M4.42M-202.31M-16.21M-195.64M0.80M-96.30M-92.80M3.90M-97.60M-136.00M-50.00M3.90M-44.40M-27.30M3.60M
Other financing activities (as filed)
-0.16M649.99M-650.44M-13.43M-0.12M-0.31M-9.81M-4.78M-0.60M-0.20M-3.10M-30.10M-0.10M-2.50M-0.40M614.10M-614.20M-5.10M
Cash from Financing ActivitiesCash from Financing
4.64M1,190.29M-121.33M-8.77M-86.60M4.31M-202.74M-26.60M-200.57M-96.60M-96.00M-26.20M-97.70M-136.30M-52.50M3.30M-44.00M-27.60M-1.60M
Additional items
Exchange Rate EffectFX Effect
-1.46M6.88M6.79M7.50M-18.17M-2.00M2.67M6.22M-6.49M2.70M3.80M-7.40M10.10M-1.80M-16.20M1.10M5.90M5.40M-0.60M
Change in Cash
-393.39M331.52M-205.75M-78.66M-83.71M29.96M-74.02M67.83M-53.87M29.40M-26.10M4.50M77.60M33.30M-151.40M26.50M134.00M-23.20M9.80M-51.70M
Ending Cash Balance
471.10M802.66M596.91M518.24M434.50M464.50M390.48M458.32M404.40M433.80M407.70M412.20M489.80M523.10M371.70M398.20M532.20M509.00M518.80M467.10M
Free Cash FlowFCF
114.72M17.42M35.97M-16.58M44.79M62.39M63.44M53.63M38.74M29.60M55.30M123.40M81.30M95.50M70.80M89.20M119.10M78.10M66.70M65.20M
Net Cash FlowNCF
-391.89M324.65M-212.51M-86.19M-65.55M31.96M-76.67M61.60M-47.38M26.70M-29.90M11.90M67.50M35.10M-135.20M25.40M134.00M-29.10M4.40M-51.10M
Interest Paid
0.40M0.31M0.13M23.53M0.43M22.48M1.05M22.86M1.11M22.40M0.90M22.30M0.90M22.20M0.90M22.40M1.10M22.40M0.90M22.40M
Income Taxes PaidTaxes Paid
30.78M14.32M71.83M51.71M20.44M13.28M18.27M9.41M88.63M3.80M48.40M23.50M23.70M7.90M48.20M-1.80M7.30M11.00M13.30M16.10M

Bio-Rad Laboratories Cash Flow Statement API

Pull Bio-Rad Laboratories's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BIO&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY